Michael Gnant, MD, Medical University of Vienna
Advertisement
Articles by Michael Gnant, MD, Medical University of Vienna
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA+ mHSPC
2
Shorter Venetoclax Plus Azacitidine Schedule Falls Short in AML
3
Secondary End Point ADC Data Add Context to HER2+ and Triple-Negative Breast Cancer Care
4
How Is Optune Pax Reshaping Locally Advanced Pancreatic Cancer Care?
5